Back to Agenda
Panel Discussion (Japanese)
Session Chair(s)
![Katsumi Tanaka](/_Images/member/Generic_Image_Missing-Profile.jpg)
Katsumi Tanaka
Showa University Koto Toyosu Hospital, Japan
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan
Speaker(s)
Giovanna Ferrari, PhD
Pfizer Ltd, United Kingdom
Regional Labelling Lead, Senior Director
Daniel Fritz, MBA
Novartis, Switzerland
Supply Chain Architect / PharmaLedger Industry Project Lead
Patrick Maher
Novartis, Switzerland
PharmaLedger ePI use case Co-Lead / Senior Operations Manager SPT/ TEP
Ken Thursby
MSD, United Kingdom
PharmaLedger ePI use case Co-Lead
Masayuki Muraoka
Ministry of Health, Labor and Welfare, Japan
Deputy Director, Pharmaceutical Safety and Environmental Health Bureau
![Naotaka Ono](/_Images/member/Generic_Image_Missing-Profile.jpg)
Naotaka Ono
AstraZeneca Japan, Japan
![Makoto Komura](/_Images/member/Generic_Image_Missing-Profile.jpg)
Makoto Komura
National Center for Child Health and Development, Japan
![Takeo Miyake](/_Images/member/Generic_Image_Missing-Profile.jpg)
Takeo Miyake
Yuyama Co.,Ltd, Japan
![Mai Okamoto](/_Images/member/Generic_Image_Missing-Profile.jpg)
Mai Okamoto
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Office of Safety I
Have an account?